Generate Biomedicines remote roles

• Director, Clinical Scientist (Respiratory)

  Company: Generate Biomedicines

  Location: Worldwide

  Salary: $186k - $279k

  Job type: full-time. Experience level: staff.

  Skills: Clinical Trial Design, Protocol Development, Regulatory documentation, Clinical data analysis, Medical Monitoring, Respiratory medicine.

  The Role: Generate:Biomedicines is seeking a highly motivated and experienced Director, Clinical Scientist to support the development of our respiratory programs, with a focus on asthma and COPD.

• Director, Clinical Scientist

  Company: Generate Biomedicines

  Location: United States

  Salary: $186k - $270k

  Job type: full-time. Experience level: staff.

  Skills: Clinical Trial Design, Protocol Development, Regulatory documentation, Medical Monitoring, GCP, Data Analysis.

  The Role: Generate:Biomedicines is seeking a highly motivated and experienced Director, Clinical Scientist to support the development of our respiratory programs, with a focus on asthma and COPD.

• Senior eTMF Specialist

  Company: Generate Biomedicines

  Location: Worldwide

  Salary: $94k - $132k

  Job type: full-time. Experience level: mid.

  Skills: Veeva Vault, GCP, Regulatory Compliance, CRO Oversight, eTMF management, Clinical study operations.

  The Role: We are seeking a dedicated Senior eTMF Specialist who supports sponsor-side eTMF operations and CRO oversight activities for assigned clinical studies. This role is responsible for execution of TMF management activities, ensuring TMFs are inspection-ready, complete, and compliant.

• Director, Clinical Scientist (Respiratory Indications)

  Company: Generate Biomedicines

  Location: Worldwide

  Salary: $186k - $279k

  Job type: full-time. Experience level: senior.

  Skills: Clinical Trial Design, Protocol Development, Data Analysis, Regulatory documentation, GCP, Cross-functional Collaboration.

  The Role: Generate:Biomedicines is seeking a highly motivated and experienced Director, Clinical Scientist to support the development of our respiratory programs, with a focus on asthma and COPD.